Medscape Conference Coverage, based on selected sessions at the:
American Urological Association 2006 Annual Meeting
May 20 - 25, 2006, Atlanta, Georgia

This activity is not sanctioned by, nor a part of, the American Urological Association.


Also On This Page:Topic OverviewsExpert InterviewsConference News
Topic Overviews
Prostate Cancer CME
Physicians - up to 1.5 AMA PRA Category 1 credit(s)
Screening for Prostate Cancer: 2006 AUA Highlights
Mitchell H. Sokoloff, MD
Localized Prostate Cancer: New Data From AUA 2006
David F. Penson, MD, MPH
Advanced Prostate Cancer: AUA 2006 Update
Siamak Daneshmand, MD

Benign Prostatic Hyperplasia CME/CE
Physicians - up to 1.25 AMA PRA Category 1 credit(s)™;
Nurses - 1.5 ANCC continuing education contact hours
Pharmacists - up to 1.25 ACPE continuing education credits for pharmacists (0.125 CEUs)

Natural History, Epidemiology, and Evaluation of BPH: AUA 2006 Findings
Claus G. Roehrborn, MD
Medical and Hormonal Therapy for BPH: New Results From 2006 AUA
Claus G. Roehrborn, MD
Minimally Invasive and Surgical Treatments for BPH: Highlights of AUA 2006
Claus G. Roehrborn, MD

Kidney and Bladder Cancers CME
Physicians - up to 1.0 AMA PRA Category 1 credit(s)
Renal Cancer: AUA 2006 Research Highlights
Samir Taneja, MD
Bladder Cancer Highlights from AUA 2006
Cheryl Lee, MD

Urinary Incontinence and Voiding Dysfunctions CME
Physicians - up to 1.0 AMA PRA Category 1 credit(s)
Surgical Management of UI and Pelvic Prolapse: 2006 AUA Results
David Ginsberg, MD
Medical Management of the Overactive Bladder: AUA 2006 Highlights
Roger Dmochowski, MD

Male Sexual Function and Infertility CME
Physicians - up to 1.0 AMA PRA Category 1 credit(s)
Sexual Dysfunction and Related Topics: Highlights From AUA 2006
Wayne J. G. Hellstrom, MD, FACS
Male Infertility: Highlights From AUA 2006
Erin T. Bird, MD
Parviz Kavoussi, MD
Expert Interviews
5-Alpha-Reductase Inhibitors and the Prevention of Prostate Cancer: An Expert Interview With Steven A. Kaplan, MD
At the 2006 AUA meeting, we spoke to Steven A. Kaplan, MD, about the current role of the 5-AR inhibitors for the prevention of prostate cancer and issues relevant to clinical practice.
Antimuscarinic Drugs and Memory Loss in Patients With Overactive Bladder: An Expert Interview With Dr. Gary Kay
What does an abundance of physical symptoms predict? Which antidepressants might be more effective in treating these symptoms and why? What effect does psychotherapy have on somatic symptoms?
Conference News
TURP Does Not Affect Erectile Function or Sexual Activity 12 Years After Surgery 5/26/06
[Medscape Medical News]
Long-term follow-up data suggest that transurethral resection of the prostate does not adversely affect sexual function, and they indicate that erectile problems often precede rather than follow surgery.
PDE-5 Inhibitor Monotherapy Effective in Treating Lower Urinary Tract Symptoms 5/25/06
[Medscape Medical News]
Three new studies support the use of phosphodiesterase-5 inhibitors for the resolution of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Urethral Injection of Muscle Stem Cells May Relieve Urinary Incontinence 5/22/06
[Medscape Medical News]
Urinary incontinence was cured after injection of stem cells in 111 of 130 patients.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Urological Association. These materials and the related activity are not sanctioned by the American Urological Association or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2006 Medscape.

 


GlaxoSmithKline, Novartis

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.